IL-28B predicts response to chronic hepatitis C therapy – fine-mapping and replication study in Asian populations
Hidenori Ochi(Hiroshima University), Kazuaki Chayama(RIKEN Center for Integrative Medical Sciences), C. Nelson Hayes(Hiroshima University), Michio Imamura(Hiroshima University), Hiromi Abe(Hiroshima University), Tatsuhiko Tsunoda(University of California San Diego), Nobuhiko Hiraga(RIKEN Center for Integrative Medical Sciences), Jia‐Horng Kao(National Taiwan University Hospital), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Shiomi Aimitsu(Japanese Red Cross Hiroshima College of Nursing), T Maekawa(RIKEN Center for Integrative Medical Sciences), Yusuke Nakamura(Rissho University), Hiromitsu Kumada(Toranomon Hospital), Rikita Nakano(Sumitomo Dainippon Pharma (Japan)), Yoshiiku Kawakami(Hiroshima University Hospital), Yasufumi Hayashida(Hiroshima University)
Cited by 54
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k